Detection and analysis of chiral molecules as disease biomarkers

Y Liu, Z Wu, DW Armstrong, H Wolosker… - Nature Reviews …, 2023 - nature.com
The chirality of small metabolic molecules is important in controlling physiological processes
and indicating the health status of humans. Abnormal enantiomeric ratios of chiral molecules …

Astrocytes and behavior

P Kofuji, A Araque - Annual review of neuroscience, 2021 - annualreviews.org
Animal behavior was classically considered to be determined exclusively by neuronal
activity, whereas surrounding glial cells such as astrocytes played only supportive roles …

d-amino Acids in Health and Disease: A Focus on Cancer

JJAJ Bastings, HM van Eijk, SW Olde Damink… - Nutrients, 2019 - mdpi.com
d-amino acids, the enantiomeric counterparts of l-amino acids, were long considered to be
non-functional or not even present in living organisms. Nowadays, d-amino acids are …

Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor

HY Lane, CH Lin, MF Green, G Hellemann… - JAMA …, 2013 - jamanetwork.com
Importance In addition to dopaminergic hyperactivity, hypofunction of theN-methyl-d-
aspartate receptor (NMDAR) has an important role in the pathophysiology of schizophrenia …

d-serine levels in Alzheimer's disease: implications for novel biomarker development

C Madeira, MV Lourenco, C Vargas-Lopes… - Translational …, 2015 - nature.com
Alzheimer's disease (AD) is a severe neurodegenerative disorder still in search of effective
methods of diagnosis. Altered levels of the NMDA receptor co-agonist, d-serine, have been …

Astrocyte-induced synaptogenesis is mediated by transforming growth factor β signaling through modulation of D-serine levels in cerebral cortex neurons

LP Diniz, JC Almeida, V Tortelli, CV Lopes… - Journal of Biological …, 2012 - ASBMB
Assembly of synapses requires proper coordination between pre-and postsynaptic
elements. Identification of cellular and molecular events in synapse formation and …

D-Serine: potential therapeutic agent and/or biomarker in schizophrenia and depression?

MAB MacKay, M Kravtsenyuk, R Thomas… - Frontiers in …, 2019 - frontiersin.org
D-Serine is a potent co-agonist at the NMDA glutamate receptor and has been the object of
many preclinical studies to ascertain the nature of its metabolism, its regional and cellular …

Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease

AC Paula‐Lima, J Brito‐Moreira… - Journal of …, 2013 - Wiley Online Library
Alzheimer′ s disease (AD) is the most common form of dementia in the elderly. Memory
loss in AD is increasingly attributed to soluble oligomers of the amyloid‐β peptide (AβOs) …

Glutamatergic transmission in schizophrenia: from basic research to clinical practice

J Kantrowitz, DC Javitt - Current opinion in psychiatry, 2012 - journals.lww.com
Glutamatergic transmission in schizophrenia: from basic rese... : Current Opinion in Psychiatry
Glutamatergic transmission in schizophrenia: from basic research to clinical practice : Current …

Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia

HY Meltzer, L Rajagopal, M Huang… - International Journal …, 2013 - academic.oup.com
The N-methyl-d-aspartate receptor (NMDAR) antagonists, phencyclidine (PCP), dizocilpine
(MK-801), or ketamine, given subchronically (sc) to rodents and primates, produce …